UNILAB - CSR
Corporate Social Responsibility (CSR) – UNITED LABORATORIES
United Laboratories is the largest pharmaceutical company in the Philippines. Established in 1945, it enjoys a dominant market share (around 20 percent) compared to other pharmaceutical companies operating in the Philippines. It also has a significant presence in neighboring countries such as China, Hong Kong, Singapore, Malaysia, and many others. From its early days its core mission has been to provide a wide range of high quality products at affordable prices – a doctrine virtually unchanged to this day.
Having gained so much success Unilab has time and again given back to the community through its CSR advocacies and activities. A number of them are briefly itemized and described in section 2 below.
1. Analyze its corporate social responsibility in terms of the three dimensions put forward by Porter and Kramer.
As mentioned, Unilab’s core mission (and indeed, a large part of its success) is to offer affordable medicines. Through various initiatives, it has been able to offer a wide range of products at much lower prices than other standard branded medicines. Excluding generics, Unilab’s line of drugs from Rite Med are some of the cheapest medicines in the market. This initiative can be seen as a competitive context issue as stipulated by Porter and Kramer. This is because the move was largely influenced by the competitive environment (in this issue of price advantage, the generics were considered the biggest competitors), and of the dynamics of consumer demand. Customers were looking for more affordable medicines and they had many options to choose from.
Unilab has also engaged in various community programs. Foremost among them is the Bayanihan Agad Program that aimed to help the victims of Typhoon Yolling. It has also promoted the study of science and technology through a collaboration with the UP Open University. These activities are clearly generic social issues for Unilab. While the causes are
United Laboratories is the largest pharmaceutical company in the Philippines. Established in 1945, it enjoys a dominant market share (around 20 percent) compared to other pharmaceutical companies operating in the Philippines. It also has a significant presence in neighboring countries such as China, Hong Kong, Singapore, Malaysia, and many others. From its early days its core mission has been to provide a wide range of high quality products at affordable prices – a doctrine virtually unchanged to this day.
Having gained so much success Unilab has time and again given back to the community through its CSR advocacies and activities. A number of them are briefly itemized and described in section 2 below.
1. Analyze its corporate social responsibility in terms of the three dimensions put forward by Porter and Kramer.
As mentioned, Unilab’s core mission (and indeed, a large part of its success) is to offer affordable medicines. Through various initiatives, it has been able to offer a wide range of products at much lower prices than other standard branded medicines. Excluding generics, Unilab’s line of drugs from Rite Med are some of the cheapest medicines in the market. This initiative can be seen as a competitive context issue as stipulated by Porter and Kramer. This is because the move was largely influenced by the competitive environment (in this issue of price advantage, the generics were considered the biggest competitors), and of the dynamics of consumer demand. Customers were looking for more affordable medicines and they had many options to choose from.
Unilab has also engaged in various community programs. Foremost among them is the Bayanihan Agad Program that aimed to help the victims of Typhoon Yolling. It has also promoted the study of science and technology through a collaboration with the UP Open University. These activities are clearly generic social issues for Unilab. While the causes are